VivoSeq
Other

Musculoskeletal Pain

0

Pipeline Programs↗

1

Active Trials↗

3

Companies Involved↗

Musculoskeletal Pain is an early-stage landscape with 0 programs across 3 companies. The most active players are Hope Biosciences Research Foundation, AbbVie, Novartis.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

89/100

Attrition Rate

9/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

H

Hope Biosciences Research Foundation

0 programs

PreclinicalAbbVie logo

AbbVie

0 programs

PreclinicalNovartis logo

Novartis

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

23

clinical trials

Completed16 · 70%
Unknown status3 · 13%
Withdrawn1 · 4%
No longer available1 · 4%
Terminated1 · 4%
Not yet recruiting1 · 4%

Clinical Trials

Trial Activity

23 trials

Evaluating the Effectiveness of a Multidisciplinary Health Monitoring and Preventive Intervention Model for Esports Players
Not yet recruiting·YYeditepe University·Preclinical·NCT07665333·30 enrolled
Study of the Treatment of Experimental Pain in Buprenorphine Maintained Persons With Chronic Musculoskeletal Pain
Completed·JJohns Hopkins University·Phase 1·NCT02372591·14 enrolled
MuscleCare™ Pain Relief Therapy vs. Voltaren® in the Relief of Trapezius Trigger Point Musculoskeletal Pain.
Completed·UUniversity of Toronto·Phase 4·NCT03939884·120 enrolled
Bonipar for Acute and Chronic Musculoskeletal Pain
Completed·WWinston Parris, MD·Phase 2·NCT03471507·164 enrolled
Comparison of Efficacy of Intravenous Paracetamol and Dexketoprofen for Acute Traumatic Musculoskeletal Pain
Completed·PPamukkale University·Phase 4·NCT03428503·200 enrolled
A Comparison of Proprietary Formulations of Oral Ketamine + Aspirin and Oral Ketamine Alone for Musculoskeletal Pain
Completed·—·Phase 4·NCT04860804·60 enrolled
Ibuprofen Versus Acetaminophen vs Their Combination in the Relief of Musculoskeletal Pain in the Emergency Setting
Completed·SStony Brook University·Phase 2·NCT01827475·90 enrolled
Study to Evaluate EB-001 in Reducing Musculoskeletal Pain
Completed·BBonti, Inc.·Phase 2·NCT03193593·66 enrolled
Low Dose of Cannabidiol (CBD) to Treat Mild to Moderate Musculoskeletal Pain
Completed·—·Phase 1·NCT04193631·16 enrolled
Efficacy of Lidocaine Patch in Acute Musculoskeletal Pain in the Emergency Department
Completed·—·Phase 3·NCT03571737·23 enrolled
Stepped Care for Depression and Musculoskeletal Pain
Completed·IIndiana University·Phase 4·NCT00118430·500 enrolled
Safety and Efficacy of Lumiracoxib Versus Naproxen in Acute Musculoskeletal Pain
Completed·Novartis logoNovartis·Phase 4·NCT00170898·419 enrolled
Modulation of Central Hypersensitivity in Chronic Musculoskeletal Pain by Intravenous Tropisetron
Completed·IInsel Gruppe AG, University Hospital Bern·Phase 2·NCT00889499·30 enrolled
Comparison of Efficacy of Intravenous Paracetamol and Dexketoprofen for Acute Nontraumatic Musculoskeletal Pain
Completed·PPamukkale University·Phase 4·NCT03122314·200 enrolled
Work And Vocational advicE (WAVE) in Primary Care: a Randomised Controlled Trial
Completed·KKeele University·Preclinical·NCT04543097·130 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)